253 related articles for article (PubMed ID: 34974168)
1. Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease.
Chen WR; Chen JC; Chang SY; Chao CT; Wu YR; Chen CM; Chou C
Biomed J; 2022 Dec; 45(6):914-922. PubMed ID: 34974168
[TBL] [Abstract][Full Text] [Related]
2. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
[TBL] [Abstract][Full Text] [Related]
3. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Plasmonic Biosensor Utilizing Paired Antibody and Label-Free Fe
Mandala SHS; Liu TJ; Chen CM; Liu KK; Januar M; Chang YF; Lai CS; Chang KH; Liu KC
Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677358
[TBL] [Abstract][Full Text] [Related]
5. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
Sato H; Kato T; Arawaka S
Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
[TBL] [Abstract][Full Text] [Related]
7. Plasma α-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease.
Ren J; Pan C; Wang Y; Xue C; Lin H; Xu J; Wang H; Zhang W; Xu P; Chen Y; Liu W
J Neurochem; 2022 Jun; 161(6):506-515. PubMed ID: 35234288
[TBL] [Abstract][Full Text] [Related]
8. Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser
Dutta S; Hornung S; Taha HB; Biggs K; Siddique I; Chamoun LM; Shahpasand-Kroner H; Lantz C; Herrera-Vaquero M; Stefanova N; Loo JA; Bitan G
ACS Chem Neurosci; 2023 Apr; 14(7):1238-1248. PubMed ID: 36920792
[TBL] [Abstract][Full Text] [Related]
9. Is peripheral alpha synuclein a marker for gait velocity in Parkinson's disease?
Chatterjee K; Choudhury S; Banerjee R; Siddique U; Sarkar S; Roy A; Chatterjee CS; Ghosal A; Basu P; Kumar H
Neurosci Lett; 2022 Aug; 786():136819. PubMed ID: 35905887
[TBL] [Abstract][Full Text] [Related]
10. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
[TBL] [Abstract][Full Text] [Related]
12. Rapid FRET Assay for the Early Detection of Alpha-Synuclein Aggregation in Parkinson's Disease.
Yu H; Feng R; Chen F; Wu Z; Li D; Qiu X
ACS Chem Neurosci; 2024 Apr; 15(7):1378-1387. PubMed ID: 38506367
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Diagnostic Potential of Combined Salivary and Skin Biomarkers in Parkinson's Disease.
Costanzo M; Galosi E; De Bartolo MI; Gallo G; Leodori G; Belvisi D; Conte A; Fabbrini G; Truini A; Berardelli A; Vivacqua G
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732041
[TBL] [Abstract][Full Text] [Related]
14. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
[TBL] [Abstract][Full Text] [Related]
15. Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease.
Tian C; Liu G; Gao L; Soltys D; Pan C; Stewart T; Shi M; Xie Z; Liu N; Feng T; Zhang J
Transl Neurodegener; 2019; 8():15. PubMed ID: 31123587
[TBL] [Abstract][Full Text] [Related]
16. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
Zubelzu M; Morera-Herreras T; Irastorza G; Gómez-Esteban JC; Murueta-Goyena A
Parkinsonism Relat Disord; 2022 Jun; 99():107-115. PubMed ID: 35717321
[TBL] [Abstract][Full Text] [Related]
17. Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease.
von Euler Chelpin M; Söderberg L; Fälting J; Möller C; Giorgetti M; Constantinescu R; Blennow K; Zetterberg H; Höglund K
J Parkinsons Dis; 2020; 10(4):1429-1442. PubMed ID: 33016895
[TBL] [Abstract][Full Text] [Related]
18. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
19. Oral Mucosa Derived α-Synuclein as a Potential Diagnostic Biomarker for Parkinson's Disease.
Zheng Y; Yu Z; Zhao J; Cai H; Wang Z; Wang X; Feng T
Front Aging Neurosci; 2022; 14():867528. PubMed ID: 35418851
[TBL] [Abstract][Full Text] [Related]
20. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA
Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
